Edited by Paolo Martelletti, Rami Burstein and Francesco Pierelli.
Citation: The Journal of Headache and Pain 2018 19(Suppl 1):80
Volume 19 Supplement 1
Publication costs for this supplement were funded by the 12th European Headache Federation Congress and the 32nd National Congress of the Italian Society for the Study of Headaches. PM has received grants from Allergan, Novartis and Teva. He received contributions to research from Allergan, Novartis and Teva, and acted on cosultant activities for Allergan. PM is an employee of Springer Nature. RB has received grants from Allergan, Teva, Dr. Reddy and Trigemina. He also acted on consultant activities for Avanir, Biohaven, Allergan, Teva, Alder, Alkermis, ATI, Depomed, Electocore, Neurlief, Pernix, Pervept, Tekeda and Trigemina. FP declares no competing interest.
Florence, Italy28-30 September 2018
Edited by Paolo Martelletti, Rami Burstein and Francesco Pierelli.
Citation: The Journal of Headache and Pain 2018 19(Suppl 1):80
The Journal of Headache and Pain is affiliated with the European Headache Federation and Lifting the Burden.
Speed
39 days to first decision for reviewed manuscripts only
21 days to first decision for all manuscripts
79 days from submission to acceptance
22 days from acceptance to publication
Citation Impact
4.797 - 2-year Impact Factor
4.536 - 5-year Impact Factor
1.164 - Source Normalized Impact per Paper (SNIP)
1.339 - SCImago Journal Rank (SJR)
Usage
907,595 Downloads
1921 Altmetric mentions